Le Lézard
Classified in: Mining industry, Business, Covid-19 virus
Subject: PVP

LIBRA LITHIUM CLOSES FINANCING, RAISING GROSS PROCEEDS OF $987,500


TORONTO, Oct. 27, 2023 /CNW/ - Libra Lithium Corp. ("Libra Lithium" or the "Company"), a privately-held, Canadian lithium explorer, is pleased to announce the closing of a non-brokered private placement of 6,099,995 common shares at $0.15 per share and 362,500 "flow-through" common shares at $0.20 per share for gross proceeds of $987,500. No warrants or dilutive instruments were issued. As of today, the Company has 40,518,051 shares issued and outstanding, with zero warrants.

"We would like to thank our investor base for their persistent support. We continue to put our money where our mouth is and are proud to have had insiders contribute over $300,000 towards this latest financing," said Koby Kushner, CEO of Libra Lithium.

"Since inception, Libra Lithium has raised approximately $1,850,000. We continue to use these funds to generate and explore one of the largest grassroots lithium portfolios in Canada, with over 80,000 ha across the Thunder Bay, Ontario and James Bay, Quebec regions. With prospecting season wrapping up, we look forward to sharing our initial findings from the hundreds of pegmatites sampled over the last few months. Results are expected in the coming weeks," said Kushner.

Regional map showing Libra Lithium's project locations (CNW Group/Libra Lithium)

About Libra Lithium Corp.

Libra Lithium is focused on advancing and developing a portfolio of grassroots lithium projects in Canada. Libra Lithium's asset portfolio includes its 100%-owned Flanders North, Flanders South, Burton, Tennant, Battery Hill, Bitchu, Kivinen and Twist lithium projects, as well as an option to earn a 100% interest in the Soules Bay and Caron lithium projects. Together, these projects span approximately 80,000 ha of prospective ground near Ontario's Thunder Bay Mining District. Libra Lithium also holds a 100% interest in the Nemiscau lithium project in James Bay, Quebec, where several pegmatites, up to 100m wide, have been mapped. The Libra Lithium team comprises a mix of seasoned executives, engineers and geoscientists, with extensive experience in mining and mineral exploration, capital markets, asset management, energy, and First Nations engagement.

Reader Advisories

Certain statements contained in this press release constitute "forward-looking information" as such term is ??????defined in applicable Canadian securities legislation. The words "may", "would", "could", "should", "potential", ???????"will", "seek", "intend", "plan", "anticipate", "believe", "estimate", "expect", "outlook", and similar expressions ?????as ?they relate to the Company, are intended to ?identify forward-looking information. All statements ??other ?than statements of ??historical fact may be forward-?looking information. Such statements reflect the ??Company's ?current views and ??intentions with respect to future ?events, and current information available to the ??Company, and ?are subject to ??certain risks, uncertainties and ?assumptions. Many ?factors could cause the actual ??results, ?performance or achievements that may be ?expressed ?or implied by such ?forward-looking information to ??vary from ?those described herein should one or more ?of these ?risks or ?uncertainties materialize. Examples of such ??risk factors ?include, without limitation: risks related ?to credit, market ???(including equity, commodity, foreign ?exchange and interest ?rate), ?liquidity, operational ??(including technology ?and ?infrastructure), reputational, ?insurance, strategic, ?regulatory, legal, ?environmental, and ?capital adequacy, and other risks and uncertainties related to the Company's prospects, properties and business; political and regulatory risks associated with mining and exploration activities and operations; the ??general business and economic ?conditions in the regions ?in which the ?Company operates; ?the ability of the ??Company to execute on key priorities, ?including the successful ?completion of ?acquisitions, ?business retention, and ??strategic plans and to attract, develop ?and retain key ?executives; ??the ability to implement business ?strategies and ?pursue business opportunities; low ?profit ?market segments; ??disruptions in or attacks (including ?cyber-attacks) on ?the Company's information ?technology, ?internet, network ??access or other voice or data ?communications systems or ?services; the evolution of ?various types ?of fraud or other ??criminal behavior to which ?the Company is exposed; the ?failure of third parties to ?comply with ?their obligations to ??the Company or its ?affiliates; the impact of new and ?changes to, or application of, ?current ?laws and regulations; ??granting of permits ?and licenses in a highly ?regulated ?business; the overall ?difficult ??litigation environment; ?increased competition; ?changes in ?foreign currency rates; ?increased ??funding costs and market volatility due to ?market illiquidity and ?competition for ?funding; the ?availability of funds ??and resources to pursue operations; ?critical accounting ?estimates and changes ?to accounting ?standards, policies, ??and methods used by the Company; ?the occurrence of ?natural and unnatural ?catastrophic ?events and claims ??resulting from such events; and risks ?related to COVID-19. Should any ?factor affect ?the Company in an unexpected manner, or ?should ???assumptions underlying the forward-looking ?information prove ?incorrect, the actual results or events may ?differ ???materially from the results or events predicted. ?Any such forward-?looking information is expressly qualified ?in its ???entirety by this cautionary statement. Moreover, ?the Company ?does not assume responsibility for the ?accuracy or ???completeness of such forward-looking ?information. The ?forward-looking information included in this ?press release ???is made as of the date of this press ?release and the ?Company undertakes no obligation to publicly ?update or revise ???any forward-looking information, ?other than as ?required by applicable law?.?

The common shares have not been, and will not be, registered under the U.S. Securities Act or any U.S. state securities laws, and may not be offered or sold in the United States or to, or for the account or benefit of, U.S. persons absent registration or any applicable exemption from the registration requirements of the U.S. Securities Act and applicable U.S. state securities laws. This release shall not constitute an offer to sell or the solicitation of an offer to buy securities in the U.S., nor shall there be any sale of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful.

SOURCE Libra Lithium


These press releases may also interest you

at 17:20
The Phase IIa COURSE trial was a proof-of-concept study in people with moderate to very severe chronic obstructive pulmonary disease (COPD) with a broad range of blood eosinophil counts (BEC) and irrespective of emphysema, chronic bronchitis or...

at 17:15
Amgen and AstraZeneca today announced the results of the Phase 2a COURSE trial evaluating Tezspire® (tezepelumab-ekko) in people with moderate to very severe chronic obstructive pulmonary disease (COPD) with a broad range of baseline blood...

18 mai 2024
Emmy-winning actor and St. Louis native Jon Hamm took the stage Saturday, May 18, to offer words of wisdom to the newest graduates of Saint Louis University (SLU) during the University's spring commencement in St. Louis. ...

18 mai 2024
Nearly 900 undergraduates of the Class of 2024 celebrated their send-off from Bentley University in a very different way than their 2020 arrival amid the COVID-19 pandemic. The 105th undergraduate commencement ceremony was marked by maskless smiles,...

18 mai 2024
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...

18 mai 2024
Mirum Pharmaceuticals, Inc. today announced data presented during the 56th European Society for Paediatric, Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Annual Meeting which took place this week in Milan, Italy. Data from LIVMARLI®...



News published on and distributed by: